Virtual Event
-
VRBPAC Meeting on COVID-19 Vaccine Strain Composition Decisions
Virtual Event
VRBPAC Meeting on COVID-19 Vaccine Strain Composition Decisions
The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on